<DOC>
	<DOCNO>NCT01998620</DOCNO>
	<brief_summary>This evaluation adenosine methionine treatment chronic hepatitis b patient cholestasis efficacy safety multicenter , randomize , open label clinical trial .</brief_summary>
	<brief_title>Efficacy Safety S-adenosyl-L-methionine Treatment Chronic Hepatitis B Patients With Cholestasis</brief_title>
	<detailed_description>evaluation adenosine methionine treatment chronic hepatitis b patient cholestasis efficacy safety</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Hepatitis B , Chronic</mesh_term>
	<mesh_term>Cholestasis</mesh_term>
	<criteria>1. 1865 year old 2. diagnose hepatitis B , previous HBV HBsAg ( + ) &gt; 6 month , HBsAg HBV DNA ( + ) 3. intrahepatic cholestasis : meet EASL 2009 diagnose criterion ALP &gt; 1.5ULN GGT &gt; 3ULN STB &gt; 2ULN 1. liver mass , liver carcinoma 2. liver failure 3. nonhepatic disease cause jaundice 4. obstructive jaundice</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Hepatitis B</keyword>
	<keyword>Cholestasis</keyword>
</DOC>